Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.
Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.
Writer Megan Warrender looks at strengthening research and innovation in strategically important areas such as automation, antibiotic resistance and quantum technology.
Nina Lindfors, Director of Teaching and Research at Helsinki University Hospital, illuminates us about a new approach to infection treatment that concerns an antibacterial bioactive glass for bone reconstruction.
Peter Jackson, Executive Director of the AMR Centre, describes new initiatives and partnerships that point the way forward for the UK’s antimicrobial resistance response.
Daniel Berman, Head of Global Health, Nesta Challenges, highlights the need for radical change in how innovation is funded and prioritised to ensure an antibiotic future given AMR is still climbing, even though behaviours are changing.
Only 11% of Brits see antimicrobial resistance as a serious threat to society, despite the outgoing UK Chief Medical Officer saying earlier this year that Superbugs “could kill us before climate change does”.
The Keep Antibiotics Working campaign is back to alert the public to the risks of antibiotic resistance, urging people to always take their doctor, pharmacist or nurse’s advice.
Resistance to antibiotics used for treating harmful bacteria related to a variety of stomach conditions has more than doubled in 20 years, new research presented at UEG Week Barcelona 2019 has shown.
Paula Gomes, Associate Professor of Chemistry and Senior Researcher in Bioorganic and Peptide Chemistry at the University of Porto, Portugal, explains why peptides are amongst the most promising molecules for the future.
The EU-funded project FLEXPOL (GA number 721062) offers an affordable approach to prohibit the spread of bacteria and healthcare-associated infections using cost-effective and sustainable film products.
